Top news of the week: 15.06.2021.
Healthcare
FDA Approval of New Alzheimer’s Drug May Boost Prospects of Other Treatments
The FDA’s reasoning for greenlighting Biogen’s Aduhelm could bode well for other Alzheimer’s drugs targeting the disease in a similar way.
Dartmouth researchers’ company aims to improve pancreatic cancer testing, treatment
LEBANON — There are cancers, and there are worse cancers. Then there is pancreatic cancer.This year 60,000 people will be diagnosed with pancreatic cancer, according to the American Cancer ...
Controversial drug approval stokes concern about lack of a permanent FDA chief
Janet Woodcock did not release a statement with the approval — noteworthy considering it was the first new Alzheimer’s drug in nearly two decades.
Sorrento's COVID Test Approved in Mexico
This and other recent developments involving Sorrento Therapeutics' pipeline and partners are covered in a Dawson James Securities report.
BioSpace Movers & Shakers, June 11
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Novavax Covid vaccine highly effective in U.S. trials, including against variants, company says
Novavax said it plans to apply to the Food and Drug Administration for emergency use authorization in the third quarter.
Biotech Pride: 19 Industry Leaders Who Identify as LGBTQ
Scientists have created mRNA vaccines that are saving millions of lives. Better cancer drugs are in the works. Gene editing technologies, and gene therapies, offer potential cures. Teams of ...
Ocugen to pursue a BLA path in the US for its COVID-19 vaccine candidate
Company intends to work with the FDA towards filing a Biologics License Application (BLA) in the USCompany to engage with Health Canada to seek...